Stasenko, Marina
Smith, Evan
Yeku, Oladapo
Park, Kay J.
Laster, Ian
Lee, Kwangkook
Walderich, Sven
Spriggs, Elizabeth
Rueda, Bo
Weigelt, Britta
Zamarin, Dmitriy
Rao, Thapi Dharma
Spriggs, David R.
Funding for this research was provided by:
National Institutes of Health (P30 CA008748, P30 CA008748, P30 CA008748, PO1-190174-01A1, P30 CA008748, P30 CA008748, PO1-190174-01A1, P30 CA008748, PO1-190174-01A1)
Article History
Received: 2 April 2020
Accepted: 19 January 2021
First Online: 12 February 2021
Competing interests
: Memorial Sloan Kettering submitted a patent application for the 14D11 antibody and other anti-galectin-3 antibodies in February of 2018 and decisions about this patent are pending. It has not been licensed for production or testing. DS, MS and TDR are listed as inventors. No other competing interests are present for any of the other authors.